BGB-3111
Showing 1 - 25 of 109
Lymphoma, Leukemia Trial in Australia, China (Zanubrutinib, Tislelizumab)
Completed
- Lymphoma
- Leukemia
-
Darlinghurst, New South Wales, Australia
- +9 more
Mar 16, 2022
Primary Membranous Nephropathy Trial (Zanubrutinib, Tacrolimus)
Not yet recruiting
- Primary Membranous Nephropathy
- (no location specified)
Jan 23, 2023
Relapsed/Refractory Marginal Zone Lymphoma Trial in Westbury (Zanubrutinib, Rituximab, Lenalidomide)
Recruiting
- Relapsed/Refractory Follicular Lymphoma
- Marginal Zone Lymphoma
- Zanubrutinib
- +3 more
-
Westbury, New YorkClinical Research Alliance, Inc.
Nov 14, 2022
Waldenström's Macroglobulinemia (WM) Trial in China (Zanubrutinib)
Completed
- Waldenström's Macroglobulinemia (WM)
-
Beijing, Beijing, China
- +10 more
Mar 7, 2022
B-cell Lymphoid Malignancies Trial in Australia, Korea, Republic of, United States (Zanubrutinib, Obinutuzumab)
Completed
- B-cell Lymphoid Malignancies
-
Fort Myers, Florida
- +14 more
Mar 1, 2022
CNS Lymphoma Trial in Beijing (Zanubrutinib)
Recruiting
- CNS Lymphoma
-
Beijing, Beijing, ChinaPeking University People's Hospital
Aug 1, 2022
Marginal Zone Lymphoma, Follicular Lymphoma, DLBCL Trial in China (Zanubrutinib, Rituximab)
Completed
- Marginal Zone Lymphoma
- +2 more
-
Harbin, Heilongjiang, China
- +3 more
Oct 26, 2021
Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma Trial in Boston (Venetoclax, Zanubrutinib)
Recruiting
- Chronic Lymphocytic Leukemia (CLL)
- Small Lymphocytic Lymphoma
-
Boston, Massachusetts
- +2 more
Mar 16, 2022
Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Trial in Houston (Rituximab, Zanubrutinib)
Recruiting
- Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
- Rituximab
- Zanubrutinib
-
Houston, TexasM D Anderson Cancer Center
Jul 9, 2022
Lupus Nephritis Trial in Guangdong (Zanubrutinib, Placebo)
Recruiting
- Lupus Nephritis
- Zanubrutinib
- Placebo
-
Guangdong, Guangzhou, ChinaGuangdong General Hospital
Apr 19, 2022
Refractory Mantle Cell Lymphoma, Relapsed Mantle Cell Lymphoma Trial in China (Zanubrutinib)
Completed
- Refractory Mantle Cell Lymphoma
- Relapsed Mantle Cell Lymphoma
-
Beijing, Beijing, China
- +13 more
Oct 8, 2021
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Follicular Lymphoma Trial in Australia, China (BGB-10188,
Recruiting
- Chronic Lymphocytic Leukemia
- +9 more
- BGB-10188
- +2 more
-
Adelaide, Australia
- +12 more
Jan 6, 2023
Diffuse Large B Cell Lymphoma Trial in Hangzhou (Rituximab, Lenalidomide, Zanubrutinib and RCHOP)
Not yet recruiting
- Diffuse Large B Cell Lymphoma
- Rituximab, Lenalidomide, Zanubrutinib and RCHOP
-
Hangzhou, Zhejiang, ChinaZhejiang Cancer Hospital
Mar 21, 2022
B-cell Malignancies Trial in Australia (Zanubrutinib, Fluconazole, Diltiazem)
Completed
- B-cell Malignancies
- Zanubrutinib
- +4 more
-
Concord, New South Wales, Australia
- +6 more
Jul 18, 2022
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Duarte (procedure, biological, drug)
Not yet recruiting
- Chronic Lymphocytic Leukemia
- Small Lymphocytic Lymphoma
- Biospecimen Collection
- +4 more
-
Duarte, CaliforniaCity of Hope Medical Center
Jan 30, 2023
Diffuse Large B-cell Lymphoma Trial in China (Zanubrutinib)
Completed
- Diffuse Large B-cell Lymphoma
-
Beijing, Beijing, China
- +10 more
Oct 11, 2021
Healthy, Male Trial in Daytona Beach (Zanubrutinib, Rifabutin)
Completed
- Healthy
- Male
-
Daytona Beach, FloridaCovance Clinical Research Unit
Aug 30, 2021